Date Field | Doc. No. | Description (Pages) |
---|
Jun 18, 2015 | 112 | Mandate issued to the United States District Court for the District of New Jersey. Costs taxed in the amount of $1853.80. Service as of this date by Clerk of Court. [249735] [FMS] [Entered: 06/18/2015 03:55 PM] (1) |
May 21, 2015 | 109 | Bill of Costs for Appellees Apotex Corp. and Apotex, Inc.. Service: 05/21/2015 by email. Objection to Bill of Costs due on 06/08/2015. [242704] [Richard Basile] [Entered: 05/21/2015 01:45 PM] (0) |
May 21, 2015 | 110 | Bill of Costs for Appellee Sandoz Inc.. Service: 05/21/2015 by email. Objection to Bill of Costs due on 06/08/2015. [242826] [Thomas Rammer] [Entered: 05/21/2015 05:42 PM] (0) |
May 21, 2015 | 111 | Bill of Costs for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 05/21/2015 by email. Objection to Bill of Costs due on 06/08/2015. [242841] [Amy Brody] [Entered: 05/21/2015 07:05 PM] (0) |
May 7, 2015 | 108 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Nonprecedential Opinion). (For the Court: Prost,Chief Judge; Bryson,Circuit Judge and Linn,Circuit Judge). [238443] [FMS] [Entered: 05/07/2015 09:20 AM] (12) |
May 4, 2015 | 107 | Submitted after ORAL ARGUMENT by Mr. Christopher Neil Sipes, Esq. for Astrazeneca AB and AstraZeneca LP, Richard Joseph Basile for Apotex Corp. and Apotex, Inc., Taras A. Gracey for Sandoz Inc. and William A. Rakoczy for Watson Laboratories, Inc. and Breath Limited. Panel: Judge: Prost , Judge: Bryson , Judge: Linn. [237601] [JCP] [Entered: 05/04/2015 02:41 PM] (0) |
Apr 21, 2015 | 105 | 6 paper copies of the Reply Brief [93] received from Appellants AstraZeneca LP and Astrazeneca AB. [234622] [FMS] [Entered: 04/21/2015 02:53 PM] (0) |
Apr 21, 2015 | 106 | 6 paper copies of the appendix Brief [102] received from Appellants AstraZeneca LP and Astrazeneca AB. [234623] [FMS] [Entered: 04/21/2015 02:54 PM] (0) |
Apr 16, 2015 | 90 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [88], ERROR: Appellees Apotex indicated 3 min. for main argument and 2 min. for rebuttal. Only Appellants and Cross-Appellants may divide their argument time between main argument and rebuttal. CORRECTION: Appellees Apotex should promptly refile their response to the oral argument order indicating only main argument and no rebuttal time. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [233236] [KSH] [Entered: 04/16/2015 08:49 AM] (0) |
Apr 16, 2015 | 91 | Response to oral argument order from the Appellees Apotex Corp. and Apotex, Inc.. designating Richard J. Basile as arguing attorney. Designated time for argument: 5 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [233249] [Richard Basile] [Entered: 04/16/2015 09:04 AM] (0) |
Apr 16, 2015 | 97 | Notice of Correction to the Brief Doc No. [85], Brief Doc No. [84], confidential Brief Doc No. [83], confidential Brief Doc No. [82], confidential Brief Doc No. [81]. Service: 04/16/2015 by email. [233392] [Christopher Sipes] [Entered: 04/16/2015 12:12 PM] (6) |
Apr 16, 2015 | 98 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 04/16/2015 by email. [233396] [Christopher Sipes] [Entered: 04/16/2015 12:17 PM] (0) |
Apr 16, 2015 | 99 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 04/16/2015 by email. [233400] [Christopher Sipes] [Entered: 04/16/2015 12:20 PM] (0) |
Apr 16, 2015 | 100 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CORRECTED JOINT APPENDIX. Service: 04/16/2015 by email. [233404] [Christopher Sipes] [Entered: 04/16/2015 12:25 PM] (1655) |
Apr 16, 2015 | 101 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CORRECTED JOINT APPENDIX. Service: 04/16/2015 by email. [233405] [Christopher Sipes] [Entered: 04/16/2015 12:28 PM] (849) |
Apr 16, 2015 | 102 | CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for AstraZeneca LP and Astrazeneca AB [98], [99]. Number of Pages: 2516. Service: 04/16/2015 by email. Pursuant to ECF-10 six paper copies should be filed of the confidential version only. [233430] [FMS] [Entered: 04/16/2015 01:32 PM] (0) |
Apr 16, 2015 | 103 | CORRECTED APPENDIX FILED for AstraZeneca LP and Astrazeneca AB [101], [100]. Number of Pages: 2504. Service: 04/16/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/21/2015. [233446] [FMS] [Entered: 04/16/2015 01:53 PM] (2504) |
Apr 16, 2015 | 104 | Statement of Compliance with Fed. Cir. R. 33 for Appellants AstraZeneca LP and Astrazeneca AB. Service: 04/16/2015 by email. [233455] [Christopher Sipes] [Entered: 04/16/2015 02:12 PM] (4) |
Apr 15, 2015 | 82 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CONFIDENTIAL JOINT APPENDIX Service: 04/14/2015 by email. [232768] [Christopher Sipes] [Entered: 04/15/2015 12:05 AM] (0) |
Apr 15, 2015 | 83 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CONFIDENTIAL JOINT APPENDIX Service: 04/14/2015 by email. [232769] [Christopher Sipes] [Entered: 04/15/2015 12:15 AM] (0) |
Apr 15, 2015 | 84 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: JOINT APPENDIX. Service: 04/14/2015 by email. [232770] [Christopher Sipes] [Entered: 04/15/2015 12:34 AM] (0) |
Apr 15, 2015 | 85 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: JOINT APPENDIX. Service: 04/14/2015 by email. [232771] [Christopher Sipes] [Entered: 04/15/2015 12:37 AM] (0) |
Apr 15, 2015 | 86 | Response to oral argument order from the Appellants AstraZeneca LP and Astrazeneca AB. designating Christopher N. Sipes as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [232822] [Christopher Sipes] [Entered: 04/15/2015 09:41 AM] (0) |
Apr 15, 2015 | 87 | Response to oral argument order from the Appellee Sandoz Inc.. designating Taras A. Gracey as arguing attorney. Designated time for argument: 5 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [233187] [Taras Gracey] [Entered: 04/15/2015 05:53 PM] (0) |
Apr 15, 2015 | 88 | Response to oral argument order from the Appellees Apotex Corp. and Apotex, Inc.. designating Richard J. Basile as arguing attorney. Designated time for argument: 3 minutes. Designated time for rebuttal: 2 minutes. Service of other counsel by Notice of Docket Activity from this entry. [233195] [Richard Basile] [Entered: 04/15/2015 06:33 PM] (0) |
Apr 15, 2015 | 89 | Response to oral argument order from the Appellees Breath Limited and Watson Laboratories, Inc.. designating William A. Rakoczy as arguing attorney. Designated time for argument: 5 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [233197] [Amy Brody] [Entered: 04/15/2015 06:37 PM] (0) |
Apr 15, 2015 | 94 | 6 paper copies of the Opening Response Brief [75] received from Appellees Breath Limited and Watson Laboratories, Inc.. [233274] [FMS] [Entered: 04/16/2015 09:41 AM] (0) |
Apr 15, 2015 | 96 | 6 paper copies of the Opening Response Brief [77] received from Appellee Sandoz Inc.. [233277] [FMS] [Entered: 04/16/2015 09:46 AM] (0) |
Apr 14, 2015 | 79 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CONFIDENTIAL REPLY BRIEF Service: 04/14/2015 by email. [232761] [Christopher Sipes] [Entered: 04/14/2015 10:58 PM] (0) |
Apr 14, 2015 | 80 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: REPLY BRIEF. Service: 04/14/2015 by email. [232763] [Christopher Sipes] [Entered: 04/14/2015 11:00 PM] (40) |
Apr 14, 2015 | 81 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CONFIDENTIAL JOINT APPENDIX Service: 04/14/2015 by email. [232767] [Christopher Sipes] [Entered: 04/14/2015 11:52 PM] (0) |
Apr 14, 2015 | 92 | CONFIDENTIAL REPLY BRIEF FILED for Appellants AstraZeneca LP and Astrazeneca AB [79]. Number of Pages: 31. Service: 04/14/2015 by email. Pursuant to ECF-10(B), six paper copies should be filed of the confidential version only. [233257] [FMS] [Entered: 04/16/2015 09:17 AM] (0) |
Apr 14, 2015 | 93 | REPLY BRIEF FILED for Appellants AstraZeneca LP and Astrazeneca AB [80]. Number of Pages: 31. Service: 04/14/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/21/2015. [233262] [FMS] [Entered: 04/16/2015 09:18 AM] (40) |
Apr 14, 2015 | 95 | 6 paper copies of the Opening Response Brief [73] received from Appellees Apotex Corp. and Apotex, Inc.. [233275] [FMS] [Entered: 04/16/2015 09:43 AM] (0) |
Apr 9, 2015 | 67 | TENDERED from Appellees Apotex Corp. and Apotex, Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 04/09/2015 by email. [231487] [Richard Basile] [Entered: 04/09/2015 07:07 PM] (0) |
Apr 9, 2015 | 68 | TENDERED from Appellees Apotex Corp. and Apotex, Inc.. Title: RESPONSE BRIEF. Service: 04/09/2015 by email, clerk. [231488] [Richard Basile] [Entered: 04/09/2015 07:08 PM] (58) |
Apr 9, 2015 | 69 | TENDERED from Appellees Breath Limited and Watson Laboratories, Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 04/09/2015 by email. [231505] [William Rakoczy] [Entered: 04/09/2015 10:14 PM] (0) |
Apr 9, 2015 | 70 | TENDERED from Appellees Breath Limited and Watson Laboratories, Inc.. Title: RESPONSE BRIEF. Service: 04/09/2015 by email. [231506] [William Rakoczy] [Entered: 04/09/2015 10:17 PM] (90) |
Apr 9, 2015 | 71 | TENDERED from Appellee Sandoz Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 04/09/2015 by email. [231508] [Taras Gracey] [Entered: 04/09/2015 11:21 PM] (0) |
Apr 9, 2015 | 72 | TENDERED from Appellee Sandoz Inc.. Title: RESPONSE BRIEF. Service: 04/09/2015 by email. [231509] [Taras Gracey] [Entered: 04/09/2015 11:22 PM] (81) |
Apr 9, 2015 | 73 | CONFIDENTIAL BRIEF FILED for Appellees Apotex Corp. and Apotex, Inc. [67]. Number of Pages: 47. Service: 04/09/2015 by email. Pursuant to ECF-10(B) six paper copies should be filed of the confidential version only. [231969] [FMS] [Entered: 04/13/2015 09:30 AM] (0) |
Apr 9, 2015 | 74 | BRIEF FILED for Appellees Apotex Corp. and Apotex, Inc. [68]. Number of Pages: 47. Service: 04/09/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/20/2015. Appellants AstraZeneca LP and Astrazeneca AB reply brief is due 04/14/2015. [231973]--[Edited 04/13/2015 by SJ to correct reply brief due date] [FMS] [Entered: 04/13/2015 09:32 AM] (58) |
Apr 9, 2015 | 75 | CONFIDENTIAL BRIEF FILED for Appellees Breath Limited and Watson Laboratories, Inc. [69]. Number of Pages: 68. Service: 04/09/2015 by email. Pursuant to ECF-10(B) six paper copies should be filed of the confidential version only. [232005] [FMS] [Entered: 04/13/2015 10:09 AM] (0) |
Apr 9, 2015 | 76 | BRIEF FILED for Appellees Breath Limited and Watson Laboratories, Inc. [70]. Number of Pages: 68. Service: 04/09/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/20/2015. [232007] [FMS] [Entered: 04/13/2015 10:11 AM] (90) |
Apr 9, 2015 | 77 | CONFIDENTIAL BRIEF FILED for Appellee Sandoz Inc. [71]. Number of Pages: 66. Service: 04/09/2015 by email. Pursuant to ECF-10(B) six paper copies should be filed of the confidential version only. [232011] [FMS] [Entered: 04/13/2015 10:18 AM] (0) |
Apr 9, 2015 | 78 | BRIEF FILED for Appellee Sandoz Inc. [72]. Number of Pages: 66. Service: 04/09/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/20/2015. [232013] [FMS] [Entered: 04/13/2015 10:20 AM] (81) |
Apr 6, 2015 | 66 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 04/06/2015 by email. [229761] [Amy Brody] [Entered: 04/06/2015 09:29 AM] (4) |
Apr 3, 2015 | 65 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Sandoz Inc.. Service: 04/03/2015 by email. [229399] [Taras Gracey] [Entered: 04/03/2015 12:07 PM] (4) |
Apr 2, 2015 | 63 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Apotex Corp. and Apotex, Inc.. Service: 04/02/2015 by email. [229220] [Richard Basile] [Entered: 04/02/2015 04:46 PM] (4) |
Apr 2, 2015 | 64 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants AstraZeneca LP and Astrazeneca AB. Service: 04/02/2015 by email. [229253] [Christopher Sipes] [Entered: 04/02/2015 09:57 PM] (3) |
Mar 30, 2015 | 62 | 6 paper copies of the Opening Brief [60] received from Appellants AstraZeneca LP and Astrazeneca AB. [228034] [SJ] [Entered: 03/30/2015 03:46 PM] (0) |
Mar 26, 2015 | 58 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: CONFIDENTIAL OPENING BRIEF Service: 03/26/2015 by email. [227522] [Christopher Sipes] [Entered: 03/26/2015 11:52 PM] (0) |
Mar 26, 2015 | 59 | TENDERED from Appellants AstraZeneca LP and Astrazeneca AB. Title: OPENING BRIEF. Service: 03/26/2015 by email. [227523] [Christopher Sipes] [Entered: 03/26/2015 11:54 PM] (253) |
Mar 26, 2015 | 60 | CONFIDENTIAL BRIEF FILED for Appellants AstraZeneca LP and Astrazeneca AB [58]. Number of Pages: 69. Service: 03/26/2015 by email. Pursuant to ECF-10(B) six paper copies should be filed of the confidential version only. [227536] [SJ] [Entered: 03/27/2015 08:34 AM] (0) |
Mar 26, 2015 | 61 | BRIEF FILED for Appellants AstraZeneca LP and Astrazeneca AB [59]. Number of Pages: 69. Service: 03/26/2015 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/01/2015. Appellees Apotex Corp., Apotex, Inc., Breath Limited, Sandoz Inc. and Watson Laboratories, Inc. brief is due 04/09/2015. [227537] [SJ] [Entered: 03/27/2015 08:39 AM] (253) |
Mar 23, 2015 | 57 | ORDER filed granting motion to direct district court to correct clerical error in February 13, 2015 opinion [56] filed by Appellants Astrazeneca AB and AstraZeneca LP. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [226312] [SJ] [Entered: 03/23/2015 02:34 PM] (2) |
Mar 20, 2015 | 56 | MOTION of Appellants AstraZeneca LP and Astrazeneca AB PLAINTIFFS-APPELLANTS ASTRAZENECAS UNOPPOSED MOTION FOR LEAVE TO SEEK CORRECTION OF A CLERICAL ERROR IN THE DISTRICT COURTS JUDGMENT. Response/Opposition is due 04/02/2015 [Consent: unopposed]. Service: 03/20/2015 by email. [226058] [Christopher Sipes] [Entered: 03/20/2015 04:20 PM] (180) |
Mar 17, 2015 | 54 | CORRECTED ENTRY: ORDER filed granting motion to reschedule argument [52] filed by Appellees Apotex Corp. and Apotex, Inc.; denying [50] motion to reconsider order filed by Watson Laboratories, Inc. and Breath Limited. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [225001]--[Edited 03/17/2015 by SJ - Reason: to correct order action/docket text] [KSH] [Entered: 03/17/2015 02:26 PM] (0) |
Mar 17, 2015 | 55 | CORRECTED ORDER: correcting court order [54]; reason(s): Order is corrected by adding the word "order" after the date "March 12, 2015" on page 2 line 2 of the order. Service as of this date by Clerk of Court. [KSH] [Entered: 03/17/2015 03:18 PM] (2) |
Mar 16, 2015 | 52 | MOTION of Appellees Apotex Corp. and Apotex, Inc. to reschedule argument. Response/Opposition is due 03/30/2015 [Consent: not addressed]. Service: 03/16/2015 by email. [224636] [Richard Basile] [Entered: 03/16/2015 04:28 PM] (7) |
Mar 16, 2015 | 53 | Letter from Appellants AstraZeneca LP and Astrazeneca AB Letter Regarding Defendant-Appellees Watson Inc. and Breath Limited's Motion for Reconsideration. Service: 03/16/2015 by email. [224729] [Christopher Sipes] [Entered: 03/16/2015 09:37 PM] (2) |
Mar 13, 2015 | 49 | NOTICE OF CALENDARING. Panel: 1505P. Case scheduled May 06, 2015 2:00 p.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 04/15/2015. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [223878] [KSH] [Entered: 03/13/2015 09:03 AM] (0) |
Mar 13, 2015 | 50 | MOTION of Appellees Breath Limited and Watson Laboratories, Inc. to reconsider court order to expedite briefing schedule [46],court order to set briefing schedule [46],court order [46]. Response/Opposition is due 03/26/2015 [Consent: opposed]. Service: 03/13/2015 by US mail, email. [224164] [William Rakoczy] [Entered: 03/13/2015 09:27 PM] (29) |
Mar 13, 2015 | 51 | Sealed or confidential document received [Opposed Motion for Reconsideration of the Court's March 12, 2015 Order Granting Injunctive Relief Pending Appeal] (corresponding to Doc No. [50]) for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 03/13/2015 by US mail, email. [224166] [William Rakoczy] [Entered: 03/13/2015 09:31 PM] (0) |
Mar 12, 2015 | 46 | ORDER filed. AstraZeneca's motion [2] is granted. As a condition for the injunction pending appeal, AstraZeneca is required to post a $130 million bond with the district court within 7 days of the date of this order. The briefing schedule for the appeal is expedited. AstraZeneca's opening brief shall be due within 14 days of the date of this order. The appellees' briefs will be due within 14 days after the filing of AstraZeneca's opening brief. AstraZeneca's reply brief and the joint appendix will be due within 5 days of the filing of the last of the appellees' briefs. Service: 03/12/2015 by clerk. [223668] [LMS] [Entered: 03/12/2015 11:35 AM] (3) |
Mar 12, 2015 | 47 | Entry of appearance for Jay I. Alexander as of counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 03/12/2015 by email. [223839] [Christopher Sipes] [Entered: 03/12/2015 04:46 PM] (2) |
Mar 12, 2015 | 48 | Entry of appearance for Ahmed Mousa as of counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 03/12/2015 by email. [223840] [Christopher Sipes] [Entered: 03/12/2015 04:48 PM] (2) |
Mar 11, 2015 | 45 | ORDER granting motion to amend the official caption [38] filed by Appellees Watson Laboratories, Inc. and Breath Limited. The revised official caption is reflected in the order. Service: 03/11/2015 by clerk. [223186] [LMS] [Entered: 03/11/2015 08:50 AM] (2) |
Mar 4, 2015 | 43 | Certificate of Interest for the Appellants AstraZeneca LP and Astrazeneca AB. Service: 03/04/2015 by email. [221679] [Christopher Sipes] [Entered: 03/04/2015 04:15 PM] (3) |
Mar 4, 2015 | 44 | Docketing Statement for the Appellants AstraZeneca LP and Astrazeneca AB. Service: 03/04/2015 by email. [221681] [Christopher Sipes] [Entered: 03/04/2015 04:17 PM] (4) |
Mar 3, 2015 | 35 | Certificate of Interest for the Appellees Breath Limited and Watson Laboratories, Inc.. Service: 03/03/2015 by email. [221279] [Amy Brody] [Entered: 03/03/2015 02:48 PM] (4) |
Mar 3, 2015 | 36 | Certificate of Interest for the Appellees Apotex Corp. and Apotex, Inc.. Service: 03/03/2015 by email. [221296] [Richard Basile] [Entered: 03/03/2015 03:25 PM] (2) |
Mar 3, 2015 | 37 | Docketing Statement for the Appellees Apotex Corp. and Apotex, Inc.. Service: 03/03/2015 by US mail, email. [221298] [Richard Basile] [Entered: 03/03/2015 03:27 PM] (3) |
Mar 3, 2015 | 38 | MOTION of Appellees Breath Limited and Watson Laboratories, Inc. to modify the official caption. Response/Opposition is due 03/16/2015 [Consent: unopposed]. Service: 03/03/2015 by email. [221355] [Amy Brody] [Entered: 03/03/2015 05:22 PM] (10) |
Mar 3, 2015 | 39 | Docketing Statement for the Appellees Breath Limited and Watson Laboratories, Inc.. Service: 03/03/2015 by email. [221357] [Amy Brody] [Entered: 03/03/2015 05:26 PM] (6) |
Mar 3, 2015 | 40 | Certificate of Interest for the Appellee Sandoz Inc.. Service: 03/03/2015 by email. [221367] [Taras Gracey] [Entered: 03/03/2015 06:13 PM] (3) |
Mar 3, 2015 | 41 | Docketing Statement for the Appellee Sandoz Inc.. Service: 03/03/2015 by email. [221368] [Taras Gracey] [Entered: 03/03/2015 06:14 PM] (4) |
Mar 3, 2015 | 42 | Transcript Purchase Order Form for the Appellants AstraZeneca LP and Astrazeneca AB indicating that a transcript is already on file. Service: 03/02/2015 by email. [221475] [SJ] [Entered: 03/04/2015 09:58 AM] (3) |
Feb 24, 2015 | 34 | Letter from Appellants AstraZeneca LP and Astrazeneca AB Letter attaching corrected Non-Confidential versions of Dr. Vellturo Declaration and Exhibits to AstraZeneca's Reply. Service: 02/24/2015 by email. [219592] [Christopher Sipes] [Entered: 02/24/2015 02:14 PM] (111) |
Feb 23, 2015 | 32 | CONFIDENTIAL REPLY of Appellants AstraZeneca LP and Astrazeneca AB to response filed by Appellee in 15-1335 , Doc. No [30], response filed by Appellees in 15-1335 , Doc. No [28], response filed by Appellees in 15-1335 , Doc. No [12]. Service: 02/23/2015 by email. [219355] [Christopher Sipes] [Entered: 02/23/2015 11:04 PM] (1) |
Feb 23, 2015 | 33 | REPLY of Appellants AstraZeneca LP and Astrazeneca AB to response filed by Appellee in 15-1335 , Doc. No [30], response filed by Appellees in 15-1335 , Doc. No [28], response filed by Appellees in 15-1335 , Doc. No [12]. Service: 02/23/2015 by email. [219356]--[Edited 02/24/2015 by SJ - attachments #2 & #4 have been replaced (See entry #34)] [Christopher Sipes] [Entered: 02/23/2015 11:10 PM] (31) |
Feb 20, 2015 | 28 | RESPONSE of Appellees Apotex Corp. and Apotex, Inc. to the motion for temporary injunction pending appeal [2] filed by Appellants Astrazeneca AB and AstraZeneca LP in 15-1335. Service: 02/20/2015 by US mail, email. [218782] [Richard Basile] [Entered: 02/20/2015 02:15 PM] (29) |
Feb 20, 2015 | 29 | Sealed or confidential document received [Defendants-Appellees Apotex, Inc. and Apotex Corp.'s Response to Plaintiffs-Appellants' Emergency Motion for an Injunction Pending Appeal and Request for Bond] (corresponding to Doc No. [28]) for Appellees Apotex Corp. and Apotex, Inc.. Service: 02/20/2015 by US mail, email. [218804] [Richard Basile] [Entered: 02/20/2015 02:36 PM] (0) |
Feb 20, 2015 | 30 | RESPONSE of Appellee Sandoz Inc. to the motion for temporary injunction pending appeal [2] filed by Appellants Astrazeneca AB and AstraZeneca LP in 15-1335. Service: 02/20/2015 by email. [218907] [Taras Gracey] [Entered: 02/20/2015 04:41 PM] (18) |
Feb 20, 2015 | 31 | Sealed or confidential document received [CONFIDENTIAL RESPONSE of Appellee Sandoz Inc. to the motion for temporary injunction pending appeal ] (corresponding to Doc No. [28]) for Appellee Sandoz Inc.. Service: 02/20/2015 by email. [218909] [Taras Gracey] [Entered: 02/20/2015 04:45 PM] (0) |
Feb 19, 2015 | 27 | Final Notice of Docketing issued to the parties. Service as of this date by Clerk of Court. [218280] [SJ] [Entered: 02/19/2015 09:21 AM] (2) |
Feb 18, 2015 | 5 | Entry of appearance for Taras Gracey as principal counsel for Appellee Sandoz Inc.. Service: 02/17/2015 by email. [217689] [Taras Gracey] [Entered: 02/17/2015 01:51 PM] (1) |
Feb 18, 2015 | 6 | Entry of appearance for Gretchen P. Miller as of counsel for Appellee Sandoz Inc.. Service: 02/17/2015 by email. [217690] [Gretchen Miller] [Entered: 02/17/2015 01:55 PM] (1) |
Feb 18, 2015 | 7 | Entry of appearance for Thomas A. Rammer II as of counsel for Appellee Sandoz Inc.. Service: 02/17/2015 by email. [217692] [Thomas Rammer] [Entered: 02/17/2015 01:58 PM] (1) |
Feb 18, 2015 | 9 | Entry of appearance for William A. Rakoczy as principal counsel for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 02/17/2015 by email. [217735] [William Rakoczy] [Entered: 02/17/2015 04:18 PM] (3) |
Feb 18, 2015 | 10 | Entry of appearance for Amy D. Brody as of counsel for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 02/17/2015 by email. [217741] [Amy Brody] [Entered: 02/17/2015 04:44 PM] (3) |
Feb 18, 2015 | 11 | Entry of appearance for Natasha L. White as of counsel for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 02/17/2015 by email. [217746] [Natasha White] [Entered: 02/17/2015 05:12 PM] (3) |
Feb 18, 2015 | 12 | RESPONSE of Appellees Breath Limited and Watson Laboratories, Inc. to the motion for temporary injunction pending appeal [2] filed by Appellants Astrazeneca AB and AstraZeneca LP in 15-1335. Service: 02/17/2015 by email. [217769] [William Rakoczy] [Entered: 02/18/2015 12:08 AM] (158) |
Feb 18, 2015 | 13 | Sealed or confidential document received [Response to Plaintiffs-Appellants AstraZeneca's Emergency Motion for an Injunction Pending Appeal] (corresponding to Doc No. [12]) for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 02/17/2015 by email. [217770] [William Rakoczy] [Entered: 02/18/2015 12:15 AM] (0) |
Feb 18, 2015 | 14 | Entry of appearance for Richard J. Basile as principal counsel for Appellees Apotex Corp. and Apotex, Inc.. Service: 02/18/2015 by email. [217904] [Richard Basile] [Entered: 02/18/2015 11:15 AM] (2) |
Feb 18, 2015 | 15 | Entry of appearance for David W. Aldrich as of counsel for Appellees Apotex Corp. and Apotex, Inc.. Service: 02/18/2015 by email. [217909] [David Aldrich] [Entered: 02/18/2015 11:18 AM] (2) |
Feb 18, 2015 | 16 | Entry of appearance for Alyson J. DiLena as of counsel for Appellees Apotex Corp. and Apotex, Inc.. Service: 02/18/2015 by email. [217918] [Alyson DiLena] [Entered: 02/18/2015 11:23 AM] (2) |
Feb 18, 2015 | 17 | Entry of appearance for Conly S. Wythers as of counsel for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 02/18/2015 by email. [217930] [Conly Wythers] [Entered: 02/18/2015 11:34 AM] (3) |
Feb 18, 2015 | 18 | Entry of appearance for Heinz J. Salmen as of counsel for Appellees Breath Limited and Watson Laboratories, Inc.. Service: 02/18/2015 by email. [218107] [Heinz Salmen] [Entered: 02/18/2015 02:30 PM] (3) |
Feb 18, 2015 | 19 | Entry of appearance for Danielle L. Goldstein as of counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 02/18/2015 by email. [218209] [Christopher Sipes] [Entered: 02/18/2015 05:07 PM] (2) |
Feb 18, 2015 | 20 | Entry of appearance for John E. Flaherty as of counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 02/18/2015 by email. [218211] [Christopher Sipes] [Entered: 02/18/2015 05:08 PM] (2) |
Feb 18, 2015 | 21 | Entry of appearance for Keith A. Teel as of counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 02/18/2015 by email. [218213] [Christopher Sipes] [Entered: 02/18/2015 05:11 PM] (2) |
Feb 18, 2015 | 22 | Entry of appearance for Ravin R. Patel as of counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 02/18/2015 by email. [218214] [Christopher Sipes] [Entered: 02/18/2015 05:13 PM] (2) |
Feb 18, 2015 | 23 | Entry of appearance for Roderick R. McKelvie as of counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 02/18/2015 by email. [218215] [Christopher Sipes] [Entered: 02/18/2015 05:13 PM] (2) |
Feb 18, 2015 | 24 | Entry of appearance for Stephen P. Anthony as of counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 02/18/2015 by email. [218217] [Christopher Sipes] [Entered: 02/18/2015 05:17 PM] (2) |
Feb 18, 2015 | 25 | Notice of Appeal and Certified list received from the United States District Court for the District of New Jersey. Service: 02/17/2015 by email. Appellant/Petitioner's brief is due 04/23/2015. [218278] [SJ] [Entered: 02/19/2015 09:17 AM] (371) |
Feb 18, 2015 | 26 | Sealed or confidential document received [sealed district court opinion filed 2/13/15 - docket entry #1164] from district court - NJ. Service: 02/17/2015 by email. [218279] [SJ] [Entered: 02/19/2015 09:21 AM] (0) |
Feb 17, 2015 | 1 | Appeal docketed. [217644] Entry of Appearance due 03/03/2015. Certificate of Interest is due on 03/03/2015. Docketing Statement due 03/03/2015. Certified List due on 03/30/2015. [SJ] [Entered: 02/17/2015 10:50 AM] (30) |
Feb 17, 2015 | 2 | MOTION of Appellants AstraZeneca LP and Astrazeneca AB for temporary injunction pending appeal (pursuamt to FRAP 8). Response/Opposition is due 03/02/2015 [Consent: opposed]. Service: 02/16/2015 by US mail. [217645] [SJ] [Entered: 02/17/2015 11:00 AM] (416) |
Feb 17, 2015 | 3 | Sealed or confidential document received [confidential rule 8 motion & exhibits] (corresponding to Doc No. [2]) for Appellants AstraZeneca LP and Astrazeneca AB. Service: 02/16/2015 by US mail. [217646] [SJ] [Entered: 02/17/2015 11:03 AM] (0) |
Feb 17, 2015 | 4 | Entry of appearance for Christopher N. Sipes as principal counsel for Appellants AstraZeneca LP and Astrazeneca AB. Service: 02/16/2015 by US mail. [217648] [SJ] [Entered: 02/17/2015 11:06 AM] (2) |
Feb 17, 2015 | 8 | ORDER filed requesting a response/reply to [3] [2] motion for temporary injunction pending appeal. Response is due no later than 2/20/15. Any reply is due within 3 days of submission of response. By: (Per Curiam). Service as of this date by Clerk of Court. [217709] [SJ] [Entered: 02/17/2015 02:43 PM] (2) |